ask="10.95"
ask_size="300"
average_daily_volume="201431"
bid="N/A"
bid_size="N/A"
book_value="3.69"
change="+0.20"
change_from_200_day_moving_average="0.20"
change_from_50_day_moving_average="-1.43"
change_from_52_week_high="-4.00"
change_From_52_week_low="6.72"
change_in_percent="+1.92%"
close="10.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.14"
eps_estimate_next_quarter="-0.53"
eps_estimate_next_year="-1.98"
ex_dividend_date="N/A"
float_shares="15638000"
high="10.75"
high_52_weeks="14.60"
last_trade_date="1/24/2017"
last_trade_price="10.60"
last_trade_size="4597"
last_trade_time="4:00pm"
low="10.15"
low_52_weeks="3.88"
market_capitalization="189.17M"
moving_average_200_day="10.40"
moving_average_50_day="12.03"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="29.25"
open="10.45"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+1.88%"
percent_change_from_50_day_moving_average="-11.90%"
percent_change_from_52_week_high="-27.40%"
percent_change_from_52_week_low="+173.20%"
previous_close="10.40"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.82"
price_per_sales="195.86"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="7.54"
stock_exchange="NCM"
symbol="STML"
volume="321811"
weeks_range_52="3.88 - 14.60"
